The premature closure of ROMPA clinical trial: mortality reduction in septic shock by plasma adsorption.

Carola Giménez-EsparzaCristina Portillo-RequenaFrancisco Colomina-ClimentJosé Manuel Allegue-GallegoMaría Galindo-MartínezCristina Mollà-JiménezJosé Luis Antón-PascualEnrique Mármol-PeisCristina Dólera-MorenoManuel Rodríguez-SerraJosé Luis Martín-RuízPablo Juan Fernández-ArroyoEugenia María Blasco-CíscarJosé Cánovas-RoblesEnrique González-HernándezFernando Sánchez-MoránManuel Solera-SuárezJesús Torres-TortajadaAntonio Palazón-BruVicente F Gil-Guillen

Published in: BMJ open (2019)

NCT02357433 in clinicaltrials.gov.

Keyphrases

septic shock
clinical trial
cardiovascular events
phase ii
double blind
aqueous solution
open label
study protocol
risk factors
phase iii
randomized controlled trial
type diabetes
coronary artery disease
placebo controlled